ibandronic acid ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
calcium metabolism regulator, pharmaceutical aid 1404 114084-78-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • bonviva
  • ibandronic acid
  • ibandronate
  • boniva
  • ibandronate sodium
Aminobisphosphonate that is a potent inhibitor of BONE RESORPTION. It is used in the treatment of HYPERCALCEMIA associated with malignancy, for the prevention of fracture and bone complications in patients with breast cancer and bone metastases, and for the treatment and prevention of POSTMENOPAUSAL OSTEOPOROSIS.
  • Molecular weight: 319.23
  • Formula: C9H23NO7P2
  • CLOGP: -1.52
  • LIPINSKI: 0
  • HAC: 8
  • HDO: 5
  • TPSA: 138.53
  • ALOGS: -1.38
  • ROTB: 9

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
5 mg O
6 mg P

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 3 Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine) 55 % Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 0.13 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
BA (Bioavailability) 1 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H
Vd (Volume of distribution) 0.55 L/kg Lombardo F, Berellini G, Obach RS
CL (Clearance) 1.80 mL/min/kg Lombardo F, Berellini G, Obach RS
fu (Fraction unbound in plasma) 0.15 % Lombardo F, Berellini G, Obach RS
t_half (Half-life) 14 hours Lombardo F, Berellini G, Obach RS

Approvals:

DateAgencyCompanyOrphan
May 16, 2003 FDA HOFFMANN LA ROCHE

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Osteonecrosis of jaw 1393.50 12.36 617 41343 32741 56217366
Femur fracture 1275.41 12.36 610 41350 38685 56211422
Osteonecrosis 608.66 12.36 312 41648 22903 56227204
Bone pain 596.35 12.36 404 41556 49781 56200326
Low turnover osteopathy 581.67 12.36 185 41775 3823 56246284
Atypical femur fracture 425.40 12.36 155 41805 4892 56245215
Stress fracture 382.55 12.36 158 41802 7019 56243088
Myalgia 274.65 12.36 410 41550 131615 56118492
Intramedullary rod insertion 254.14 12.36 84 41876 1967 56248140
Drug ineffective 251.73 12.36 192 41768 918797 55331310
Fracture nonunion 216.34 12.36 76 41884 2151 56247956
Exposed bone in jaw 201.70 12.36 77 41883 2771 56247336
Osteomyelitis 183.06 12.36 149 41811 24197 56225910
Pain in jaw 177.19 12.36 182 41778 39854 56210253
Dental caries 176.06 12.36 104 41856 10064 56240043
Tooth extraction 174.68 12.36 101 41859 9392 56240715
Influenza like illness 172.72 12.36 220 41740 60768 56189339
Bone disorder 167.08 12.36 129 41831 19414 56230693
Jaw disorder 161.78 12.36 78 41882 5005 56245102
Osteoporosis 158.94 12.36 195 41765 51857 56198250
Tooth disorder 158.48 12.36 140 41820 25413 56224694
Injection site extravasation 153.05 12.36 88 41872 8096 56242011
Anaemia postoperative 144.37 12.36 56 41904 2105 56248002
Vitamin D deficiency 139.65 12.36 96 41864 12074 56238033
Fall 139.52 12.36 581 41379 356929 55893178
Pain in extremity 138.41 12.36 511 41449 296920 55953187
Foot fracture 134.27 12.36 119 41841 21690 56228417
Off label use 133.62 12.36 131 41829 556049 55694058
Gastrooesophageal reflux disease 129.77 12.36 227 41733 83030 56167077
Maternal exposure during pregnancy 126.96 12.36 3 41957 189550 56060557
Acute phase reaction 125.71 12.36 31 41929 236 56249871
Osteoarthritis 125.24 12.36 219 41741 80077 56170030
Tooth fracture 122.51 12.36 83 41877 10193 56239914
Arthralgia 121.83 12.36 712 41248 500957 55749150
Rheumatoid arthritis 118.84 12.36 69 41891 382535 55867572
Exostosis of jaw 115.85 12.36 41 41919 1186 56248921
Pathological fracture 115.13 12.36 73 41887 8016 56242091
Spinal osteoarthritis 114.05 12.36 92 41868 14744 56235363
Fracture delayed union 112.63 12.36 48 41912 2305 56247802
Back pain 112.34 12.36 410 41550 236760 56013347
Open reduction of fracture 111.40 12.36 39 41921 1092 56249015
Metastases to bone 109.38 12.36 101 41859 19407 56230700
Infusion related reaction 103.56 12.36 16 41944 208915 56041192
Periodontal disease 103.51 12.36 40 41920 1488 56248619
Product use issue 97.50 12.36 12 41948 186029 56064078
Hyperlipidaemia 96.22 12.36 91 41869 18018 56232089
Fracture displacement 94.88 12.36 35 41925 1143 56248964
Extravasation 93.60 12.36 41 41919 2106 56248001
Condition aggravated 92.59 12.36 73 41887 344825 55905282
Sequestrectomy 87.46 12.36 30 41930 789 56249318
Osteitis 87 12.36 44 41916 3130 56246977
Hand deformity 86.84 12.36 3 41957 134489 56115618
Spinal compression fracture 85.52 12.36 74 41886 13060 56237047
Therapeutic product effect decreased 83.90 12.36 13 41947 169439 56080668
Osteopenia 83.01 12.36 84 41876 18057 56232050
Treatment failure 82.29 12.36 14 41946 170378 56079729
Drug intolerance 80.38 12.36 49 41911 264769 55985338
Fracture 76.24 12.36 80 41880 17938 56232169
Device failure 75.57 12.36 49 41911 5590 56244517
Systemic lupus erythematosus 74.43 12.36 21 41939 180057 56070050
Atypical fracture 71.88 12.36 24 41936 580 56249527
Rib fracture 71.73 12.36 82 41878 20227 56229880
Glossodynia 68.38 12.36 15 41945 152443 56097664
Gingivitis 68.31 12.36 52 41908 7657 56242450
Femoral neck fracture 67.94 12.36 52 41908 7719 56242388
Temporomandibular joint syndrome 66.66 12.36 39 41921 3705 56246402
Lower respiratory tract infection 66.45 12.36 5 41955 114789 56135318
Periprosthetic fracture 65.94 12.36 21 41939 435 56249672
Synovitis 64.48 12.36 20 41940 161285 56088822
Carbohydrate antigen 15-3 increased 64.40 12.36 27 41933 1244 56248863
Impaired healing 62.93 12.36 174 41786 86667 56163440
Abscess jaw 62.47 12.36 27 41933 1342 56248765
Toxicity to various agents 62.15 12.36 46 41914 224518 56025589
Resorption bone increased 61.49 12.36 26 41934 1224 56248883
Hepatic enzyme increased 60.48 12.36 26 41934 171358 56078749
Dyspepsia 60.24 12.36 167 41793 83304 56166803
Joint swelling 59.82 12.36 77 41883 289723 55960384
Bone loss 58.58 12.36 33 41927 2918 56247189
Bone density decreased 58.22 12.36 59 41901 12701 56237406
Gingival disorder 57.45 12.36 34 41926 3299 56246808
Injection site inflammation 56.68 12.36 34 41926 3382 56246725
Periodontitis 56.45 12.36 33 41927 3130 56246977
Actinomycosis 56.34 12.36 23 41937 990 56249117
Toothache 56.18 12.36 68 41892 17812 56232295
Ulna fracture 55.67 12.36 23 41937 1021 56249086
Musculoskeletal pain 55.27 12.36 159 41801 80993 56169114
Bursitis 54.84 12.36 84 41876 27498 56222609
Tooth loss 54.51 12.36 42 41918 6295 56243812
Fibrocystic breast disease 54.47 12.36 23 41937 1079 56249028
Fatigue 53.42 12.36 357 41603 788195 55461912
Diverticulum 52.01 12.36 52 41908 11014 56239093
Product use in unapproved indication 51.90 12.36 20 41940 140802 56109305
Chest pain 51.49 12.36 278 41682 189519 56060588
Pelvic fracture 51.27 12.36 54 41906 12159 56237948
Oral cavity fistula 51.23 12.36 19 41941 630 56249477
Spinal fracture 50.85 12.36 62 41898 16362 56233745
Therapeutic product effect incomplete 50.54 12.36 9 41951 106022 56144085
Jaw operation 49.79 12.36 20 41940 825 56249282
Intervertebral disc degeneration 49.40 12.36 57 41903 14197 56235910
Loose tooth 47.69 12.36 30 41930 3248 56246859
Spondylolisthesis 47.18 12.36 30 41930 3309 56246798
Jaw fracture 47.05 12.36 27 41933 2473 56247634
Tooth abscess 46.25 12.36 54 41906 13621 56236486
Metastases to liver 46.13 12.36 68 41892 21518 56228589
Hypercholesterolaemia 45.40 12.36 55 41905 14418 56235689
Oesophagitis 45.04 12.36 54 41906 14003 56236104
Scoliosis 45.01 12.36 39 41921 6894 56243213
Wound 44.47 12.36 24 41936 138780 56111327
Nasopharyngitis 44.25 12.36 60 41900 220899 56029208
Fistula 44.20 12.36 43 41917 8812 56241295
Metastases to pleura 43.35 12.36 21 41939 1361 56248746
Hypothyroidism 43.26 12.36 91 41869 38105 56212002
Isosthenuria 43.07 12.36 11 41949 98 56250009
Radius fracture 42.76 12.36 28 41932 3247 56246860
Hip fracture 42.57 12.36 74 41886 26899 56223208
Vertebral foraminal stenosis 42.48 12.36 18 41942 852 56249255
Discomfort 41.90 12.36 27 41933 141734 56108373
Oral infection 41.31 12.36 31 41929 4467 56245640
Medical device removal 39.98 12.36 19 41941 1180 56248927
Calcium deficiency 39.77 12.36 18 41942 999 56249108
Lumbar spinal stenosis 39.55 12.36 30 41930 4393 56245714
Exostosis 39.28 12.36 52 41908 14891 56235216
Hypersensitivity 39.04 12.36 83 41877 256325 55993782
Drug abuse 38.96 12.36 3 41957 67607 56182500
Rotator cuff syndrome 37.85 12.36 46 41914 12097 56238010
Blister 37.64 12.36 17 41943 108870 56141237
Pyelitis 37.31 12.36 11 41949 174 56249933
Hyperaesthesia teeth 37.26 12.36 20 41940 1608 56248499
Breast cancer recurrent 37.24 12.36 28 41932 4047 56246060
Hydrothorax 36.93 12.36 16 41944 800 56249307
Groin pain 36.91 12.36 40 41920 9300 56240807
Pulpitis dental 36.12 12.36 16 41944 844 56249263
Rash 35.93 12.36 218 41742 492829 55757278
Product dose omission issue 35.78 12.36 61 41899 204692 56045415
Pneumonia 35.75 12.36 169 41791 406929 55843178
Endodontic procedure 35.67 12.36 24 41936 2912 56247195
Osteomalacia 35.64 12.36 15 41945 698 56249409
Dental necrosis 35.45 12.36 10 41950 134 56249973
Gastritis 35.10 12.36 79 41881 34623 56215484
Bladder hypertrophy 35.04 12.36 11 41949 217 56249890
Oxygen saturation decreased 34.99 12.36 8 41952 79059 56171048
Meniscus injury 34.92 12.36 33 41927 6525 56243582
Intentional overdose 34.21 12.36 5 41955 68112 56181995
Electrocardiogram PR shortened 33.92 12.36 11 41949 242 56249865
Renal cyst 33.57 12.36 38 41922 9271 56240836
Oesophageal stenosis 32.90 12.36 23 41937 2970 56247137
Phlebitis 32.56 12.36 31 41929 6185 56243922
Compression fracture 31.63 12.36 30 41930 5959 56244148
Muscle spasms 31.19 12.36 192 41768 137179 56112928
Tonsillectomy 31.02 12.36 14 41946 772 56249335
Peripheral swelling 30.92 12.36 82 41878 234644 56015463
Wrist fracture 30.31 12.36 41 41919 11985 56238122
Folliculitis 30.16 12.36 3 41957 54976 56195131
Haemorrhoids 30.03 12.36 54 41906 20152 56229955
Febrile neutropenia 29.98 12.36 21 41939 105524 56144583
Product administration error 29.92 12.36 55 41905 20874 56229233
Intentional product use issue 29.46 12.36 19 41941 99714 56150393
Oesophageal disorder 29.35 12.36 19 41941 2161 56247946
Hysterectomy 29.18 12.36 34 41926 8557 56241550
Mitral valve prolapse 29.14 12.36 19 41941 2187 56247920
Gingival swelling 29.01 12.36 24 41936 3982 56246125
Hypotension 29.01 12.36 93 41867 250415 55999692
Osteochondrosis 28.72 12.36 15 41945 1141 56248966
Alopecia 28.66 12.36 117 41843 293341 55956766
Osteocalcin decreased 28.65 12.36 7 41953 51 56250056
Dysphagia 28.58 12.36 129 41831 81818 56168289
Hiatus hernia 28.54 12.36 52 41908 19600 56230507
Blood loss anaemia 28.45 12.36 33 41927 8264 56241843
Weight increased 28.21 12.36 83 41877 229620 56020487
Jaw fistula 28.19 12.36 7 41953 55 56250052
Rectocele 28.17 12.36 14 41946 959 56249148
Pruritus 27.44 12.36 132 41828 316491 55933616
Dental implantation 27.02 12.36 12 41948 637 56249470
Lumbar radiculopathy 26.91 12.36 17 41943 1854 56248253
Drug hypersensitivity 26.69 12.36 110 41850 275095 55975012
Internal fixation of fracture 26.58 12.36 12 41948 662 56249445
Psoriatic arthropathy 26.45 12.36 11 41949 73997 56176110
Bone graft 26.37 12.36 13 41947 875 56249232
Hypertension 26.26 12.36 288 41672 243990 56006117
Metastases to lymph nodes 26.25 12.36 30 41930 7393 56242714
Multiple organ dysfunction syndrome 26.21 12.36 4 41956 52766 56197341
Cellulitis 26.14 12.36 118 41842 74831 56175276
Intervertebral disc protrusion 26.10 12.36 53 41907 21641 56228466
Cough 25.78 12.36 103 41857 259858 55990249
Humerus fracture 25.77 12.36 31 41929 8066 56242041
Hormone receptor positive HER2 negative breast cancer 25.67 12.36 8 41952 154 56249953
Comminuted fracture 25.58 12.36 11 41949 540 56249567
Suicide attempt 25.30 12.36 6 41954 57830 56192277
Musculoskeletal chest pain 24.85 12.36 49 41911 19592 56230515
Invasive ductal breast carcinoma 24.84 12.36 28 41932 6798 56243309
Calcification metastatic 24.67 12.36 8 41952 176 56249931
Depressed level of consciousness 24.40 12.36 6 41954 56427 56193680
Dental fistula 24.33 12.36 11 41949 609 56249498
Muscle strain 24.31 12.36 29 41931 7479 56242628
Confusional state 24.28 12.36 77 41883 208078 56042029
Bone marrow oedema 24.27 12.36 13 41947 1041 56249066
Limb asymmetry 24.11 12.36 12 41948 825 56249282
Carcinoembryonic antigen increased 24.07 12.36 15 41945 1597 56248510
Hospitalisation 23.96 12.36 13 41947 74987 56175120
Muscle injury 23.86 12.36 5 41955 52495 56197612
Tibia fracture 23.76 12.36 23 41937 4685 56245422
Injection site swelling 23.72 12.36 79 41881 43499 56206608
Kyphosis 23.70 12.36 17 41943 2285 56247822
Dental plaque 23.67 12.36 7 41953 112 56249995
Depression 23.00 12.36 220 41740 179897 56070210
Osteogenesis imperfecta 22.79 12.36 9 41951 355 56249752
PIK3CA-activated mutation 22.58 12.36 12 41948 946 56249161
Spondylolysis 22.44 12.36 6 41954 65 56250042
Goitre 22.25 12.36 24 41936 5549 56244558
Therapy non-responder 22.12 12.36 9 41951 61346 56188761
Breast cancer 21.84 12.36 83 41877 48750 56201357
Thoracic vertebral fracture 21.84 12.36 21 41939 4242 56245865
Poor dental condition 21.81 12.36 9 41951 398 56249709
Seborrhoeic keratosis 21.70 12.36 15 41945 1902 56248205
Cataract operation 21.61 12.36 22 41938 4760 56245347
White blood cell count decreased 21.57 12.36 38 41922 125952 56124155
Oestrogen deficiency 21.50 12.36 7 41953 156 56249951
Creatinine renal clearance increased 21.39 12.36 10 41950 598 56249509
COVID-19 21.22 12.36 15 41945 75043 56175064
Liver injury 21.18 12.36 3 41957 41845 56208262
Tonsillar disorder 21.13 12.36 12 41948 1078 56249029
Sinusitis 21.06 12.36 76 41884 197505 56052602
Bone sequestrum 20.86 12.36 13 41947 1384 56248723
Large intestine polyp 20.76 12.36 27 41933 7600 56242507
Upper limb fracture 20.75 12.36 42 41918 17113 56232994
Hand fracture 20.67 12.36 22 41938 5011 56245096
Gastrointestinal tract irritation 20.60 12.36 9 41951 459 56249648
Arteriosclerosis 20.51 12.36 30 41930 9423 56240684
Metastases to skin 20.35 12.36 13 41947 1445 56248662
Spinal stenosis 20.25 12.36 37 41923 13977 56236130
Skeletal injury 20.24 12.36 12 41948 1168 56248939
Osteoporotic fracture 20.19 12.36 18 41942 3303 56246804
Congenital coronary artery malformation 20.17 12.36 6 41954 98 56250009
Platelet count decreased 20.17 12.36 30 41930 106353 56143754
Stress urinary incontinence 20.10 12.36 15 41945 2143 56247964
Somnolence 20.09 12.36 59 41901 163354 56086753
Tooth avulsion 19.84 12.36 5 41955 42 56250065
Metastases to spine 19.78 12.36 17 41943 2972 56247135
Bone fragmentation 19.75 12.36 10 41950 713 56249394
Metastases to adrenals 19.74 12.36 10 41950 714 56249393
Tooth infection 19.57 12.36 39 41921 15713 56234394
Breath odour 19.50 12.36 12 41948 1250 56248857
Spinal meningeal cyst 19.43 12.36 5 41955 46 56250061
Breast mass 19.34 12.36 25 41935 6994 56243113
Oral pustule 19.34 12.36 5 41955 47 56250060
Patella fracture 19.33 12.36 14 41946 1911 56248196
Appendicectomy 19.24 12.36 16 41944 2674 56247433
Lumbar vertebral fracture 19.16 12.36 21 41939 4943 56245164
Injection site phlebitis 18.99 12.36 6 41954 121 56249986
Gingival recession 18.95 12.36 12 41948 1314 56248793
Breast cancer metastatic 18.86 12.36 38 41922 15431 56234676
Arthropathy 18.82 12.36 81 41879 200194 56049913
Arthritis 18.68 12.36 133 41827 99719 56150388
Hypertonic bladder 18.63 12.36 17 41943 3215 56246892
Oral surgery 18.42 12.36 11 41949 1085 56249022
Barrett's oesophagus 18.25 12.36 9 41951 606 56249501
Dyslipidaemia 18.09 12.36 23 41937 6330 56243777
Heart rate decreased 18.07 12.36 4 41956 40423 56209684
Blood pressure fluctuation 18.02 12.36 4 41956 40356 56209751
Gingival pain 17.99 12.36 23 41937 6365 56243742
Oral disorder 17.82 12.36 26 41934 8149 56241958
Eructation 17.81 12.36 25 41935 7563 56242544
Breast calcifications 17.66 12.36 11 41949 1170 56248937
Bone lesion 17.63 12.36 21 41939 5409 56244698
Spinal disorder 17.59 12.36 27 41933 8851 56241256
Fractured sacrum 17.47 12.36 13 41947 1850 56248257
No adverse event 17.25 12.36 63 41897 36311 56213796
Death 17.23 12.36 167 41793 341259 55908848
Neck pain 17.22 12.36 91 41869 61464 56188643
Hypophosphataemic osteomalacia 17.20 12.36 6 41954 166 56249941
Bone formation increased 17.04 12.36 6 41954 171 56249936
Lymphoedema 16.76 12.36 29 41931 10501 56239606
Acute kidney injury 16.68 12.36 108 41852 240655 56009452
Erosive oesophagitis 16.63 12.36 12 41948 1628 56248479
Oesophageal pain 16.53 12.36 16 41944 3259 56246848
Atrophic vulvovaginitis 16.50 12.36 12 41948 1649 56248458
Cerumen impaction 16.49 12.36 10 41950 1014 56249093
Wheezing 16.43 12.36 19 41941 75007 56175100
Chronic hepatic failure 16.32 12.36 8 41952 532 56249575
Drug-induced liver injury 16.25 12.36 3 41957 34459 56215648
Pulmonary oedema 16.14 12.36 9 41951 51134 56198973
Injection site thrombosis 15.96 12.36 5 41955 98 56250009
Mediastinal disorder 15.95 12.36 7 41953 361 56249746
Bone metabolism disorder 15.90 12.36 7 41953 364 56249743
Cholecystectomy 15.84 12.36 27 41933 9657 56240450
Suicidal ideation 15.73 12.36 12 41948 57730 56192377
Cystocele 15.72 12.36 10 41950 1103 56249004
Cardio-respiratory arrest 15.71 12.36 11 41949 55310 56194797
Purulence 15.69 12.36 11 41949 1426 56248681
Hyperparathyroidism 15.66 12.36 14 41946 2578 56247529
Drug interaction 15.61 12.36 92 41868 209663 56040444
Bone lesion excision 15.53 12.36 4 41956 37 56250070
Tooth deposit 15.35 12.36 6 41954 230 56249877
Rhinorrhoea 15.35 12.36 12 41948 57025 56193082
Radiculopathy 15.33 12.36 20 41940 5645 56244462
Vascular procedure complication 15.32 12.36 3 41957 6 56250101
Induration 15.28 12.36 10 41950 1159 56248948
Varicose vein 15.19 12.36 18 41942 4611 56245496
Ankle fracture 15.11 12.36 36 41924 16367 56233740
Malaise 14.96 12.36 189 41771 367671 55882436
Fibula fracture 14.93 12.36 15 41945 3195 56246912
Chest wall tumour 14.90 12.36 4 41956 44 56250063
Agitation 14.81 12.36 12 41948 56024 56194083
Polyneuropathy 14.66 12.36 31 41929 13019 56237088
Jaw cyst 14.63 12.36 5 41955 130 56249977
Anxiety disorder 14.47 12.36 16 41944 3804 56246303
Peritoneal disorder 14.43 12.36 7 41953 455 56249652
Disease progression 14.40 12.36 36 41924 105137 56144970
Respiratory failure 14.25 12.36 31 41929 95031 56155076
Dental care 14.23 12.36 9 41951 983 56249124
Postmenopause 14.22 12.36 4 41956 53 56250054
Metastases to the mediastinum 14.22 12.36 7 41953 470 56249637
Synovial cyst 14.17 12.36 25 41935 9189 56240918
Type V hyperlipidaemia 14.11 12.36 7 41953 478 56249629
Ovarian cancer stage III 14.10 12.36 6 41954 287 56249820
Oral fibroma 14.09 12.36 4 41956 55 56250052
Neutrophil count decreased 14.03 12.36 10 41950 49812 56200295
Tendon calcification 14.02 12.36 4 41956 56 56250051
Cardiac arrest 13.91 12.36 27 41933 86287 56163820
Biopsy bone 13.89 12.36 4 41956 58 56250049
Tendonitis 13.83 12.36 37 41923 18060 56232047
Dental prosthesis user 13.83 12.36 4 41956 59 56250048
Abdominal discomfort 13.82 12.36 136 41824 277138 55972969
Septic shock 13.76 12.36 15 41945 60820 56189287
Cognitive disorder 13.65 12.36 10 41950 49123 56200984
Macular hole 13.63 12.36 8 41952 764 56249343
Radiotherapy 13.54 12.36 6 41954 317 56249790
Seizure 13.41 12.36 48 41912 125071 56125036
Appendix disorder 13.34 12.36 10 41950 1439 56248668
Rhinoplasty 13.24 12.36 3 41957 15 56250092
Oral neoplasm 13.14 12.36 4 41956 71 56250036
Dyspnoea 13.12 12.36 339 41621 592238 55657869
Rhinitis allergic 13.04 12.36 23 41937 8451 56241656
Oesophageal discomfort 13.04 12.36 5 41955 182 56249925
Metabolic acidosis 12.94 12.36 7 41953 40447 56209660
Wound haemorrhage 12.87 12.36 12 41948 2333 56247774
Sepsis 12.86 12.36 57 41903 139783 56110324
Tongue geographic 12.79 12.36 4 41956 78 56250029
Oral dysaesthesia 12.74 12.36 4 41956 79 56250028
Injection site cellulitis 12.70 12.36 9 41951 1187 56248920
Eustachian tube dysfunction 12.68 12.36 6 41954 369 56249738
Loss of personal independence in daily activities 12.64 12.36 26 41934 81343 56168764
Ligament sprain 12.59 12.36 27 41933 11448 56238659
Unresponsive to stimuli 12.54 12.36 4 41956 31721 56218386
Serratia infection 12.54 12.36 8 41952 887 56249220
Illness 12.54 12.36 5 41955 34506 56215601
X-ray of pelvis and hip abnormal 12.51 12.36 3 41957 20 56250087
Cataract 12.49 12.36 73 41887 51174 56198933
Psoriasis 12.48 12.36 32 41928 92660 56157447
Spinal cord herniation 12.38 12.36 3 41957 21 56250086

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Osteonecrosis of jaw 145.93 23.82 52 2169 17019 31678104
Osteonecrosis 102.56 23.82 38 2183 13846 31681277
Appetite disorder 40.31 23.82 12 2209 2213 31692910
Femur fracture 39.17 23.82 16 2205 7517 31687606
Rectal polyp 38.85 23.82 9 2212 626 31694497
Breast cancer 38.55 23.82 8 2213 333 31694790
Jaw fracture 30.34 23.82 8 2213 949 31694174
Fall 25.28 23.82 46 2175 186043 31509080

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Osteonecrosis of jaw 1393.72 13.42 546 27590 40456 70859852
Femur fracture 794.36 13.42 353 27783 35779 70864529
Osteonecrosis 515.54 13.42 245 27891 28915 70871393
Atypical femur fracture 445.57 13.42 136 28000 4707 70895601
Bone pain 403.07 13.42 251 27885 50571 70849737
Low turnover osteopathy 290.13 13.42 79 28057 1803 70898505
Stress fracture 249.02 13.42 92 28044 5758 70894550
Exposed bone in jaw 201.04 13.42 69 28067 3480 70896828
Osteomyelitis 179.90 13.42 125 28011 30193 70870115
Dental caries 153.11 13.42 79 28057 11092 70889216
Pain in jaw 152.18 13.42 130 28006 42539 70857769
Myalgia 150.56 13.42 252 27884 167640 70732668
Jaw disorder 142.75 13.42 58 28078 4688 70895620
Fracture nonunion 142.42 13.42 43 28093 1431 70898877
Bone disorder 137.54 13.42 86 28050 17404 70882904
Tooth disorder 133.41 13.42 95 28041 23843 70876465
Arthralgia 131.59 13.42 468 27668 502922 70397386
Acute phase reaction 124.12 13.42 28 28108 282 70900026
Influenza like illness 122.30 13.42 140 27996 65191 70835117
Pain in extremity 120.35 13.42 343 27793 327739 70572569
Injection site extravasation 117.41 13.42 61 28075 8685 70891623
Tooth fracture 117.10 13.42 65 28071 10562 70889746
Exostosis of jaw 111.71 13.42 34 28102 1163 70899145
Fall 107.58 13.42 403 27733 443693 70456615
Drug ineffective 106.89 13.42 130 28006 939622 69960686
Tooth extraction 106.41 13.42 60 28076 10047 70890261
Metastases to bone 96.16 13.42 76 28060 22300 70878008
Sequestrectomy 96.00 13.42 28 28108 825 70899483
Fracture displacement 94.36 13.42 30 28106 1188 70899120
Pathological fracture 93.14 13.42 54 28082 9529 70890779
Osteitis 89.58 13.42 39 28097 3744 70896564
Foot fracture 89.48 13.42 69 28067 19531 70880777
Fracture delayed union 86.21 13.42 32 28104 2027 70898281
Back pain 83.77 13.42 267 27869 270885 70629423
Impaired healing 80.84 13.42 122 28014 74252 70826056
Actinomycosis 79.42 13.42 25 28111 958 70899350
Atypical fracture 75.72 13.42 22 28114 639 70899669
Off label use 70.22 13.42 117 28019 742943 70157365
Spinal compression fracture 67.19 13.42 53 28083 15500 70884808
Jaw fracture 66.52 13.42 29 28107 2792 70897516
Gingivitis 65.85 13.42 41 28095 8229 70892079
Gastrooesophageal reflux disease 65.41 13.42 124 28012 90715 70809593
Femoral neck fracture 64.82 13.42 42 28094 9031 70891277
Oral cavity fistula 61.98 13.42 19 28117 666 70899642
Periodontal disease 61.74 13.42 24 28112 1726 70898582
Toxicity to various agents 59.88 13.42 39 28097 382133 70518175
Jaw operation 58.64 13.42 19 28117 800 70899508
Carbohydrate antigen 15-3 increased 57.71 13.42 20 28116 1038 70899270
Osteoporosis 57.12 13.42 83 28053 48824 70851484
Temporomandibular joint syndrome 53.90 13.42 27 28109 3560 70896748
Fracture 53.86 13.42 52 28084 19892 70880416
Fistula 53.40 13.42 40 28096 10841 70889467
Breast cancer recurrent 50.93 13.42 24 28112 2769 70897539
Anaemia postoperative 50.90 13.42 21 28115 1764 70898544
Vitamin D deficiency 50.63 13.42 41 28095 12446 70887862
Isosthenuria 49.68 13.42 11 28125 101 70900207
Oral infection 49.43 13.42 29 28107 5230 70895078
Extravasation 49.37 13.42 25 28111 3372 70896936
Abscess jaw 48.49 13.42 20 28116 1679 70898629
Osteoarthritis 48.24 13.42 97 28039 74050 70826258
Tooth abscess 47.06 13.42 42 28094 14547 70885761
Ulna fracture 46.89 13.42 17 28119 1007 70899301
Gingival disorder 46.17 13.42 24 28112 3418 70896890
Infusion related reaction 45.84 13.42 11 28125 197523 70702785
Hydrothorax 45.73 13.42 18 28118 1338 70898970
Device failure 44.13 13.42 28 28108 5807 70894501
Periodontitis 43.69 13.42 25 28111 4303 70896005
Injection site inflammation 43.35 13.42 23 28113 3415 70896893
Fibrocystic breast disease 43.19 13.42 14 28122 590 70899718
Periprosthetic fracture 43.06 13.42 14 28122 596 70899712
Febrile neutropenia 42.55 13.42 14 28122 204304 70696004
Resorption bone increased 41.90 13.42 17 28119 1368 70898940
Tooth loss 41.57 13.42 28 28108 6422 70893886
Spinal osteoarthritis 41.41 13.42 40 28096 15308 70885000
Drug abuse 41.17 13.42 5 28131 147251 70753057
Loose tooth 40.65 13.42 21 28115 2953 70897355
Toothache 40.52 13.42 43 28093 18387 70881921
Exostosis 39.86 13.42 38 28098 14307 70886001
Musculoskeletal pain 39.57 13.42 101 28035 90226 70810082
Dyspepsia 39.44 13.42 100 28036 88977 70811331
Electrocardiogram PR shortened 39.40 13.42 11 28125 276 70900032
Pyelitis 39.17 13.42 11 28125 282 70900026
Condition aggravated 38.75 13.42 69 28067 427566 70472742
Osteopenia 38.57 13.42 40 28096 16657 70883651
Groin pain 37.52 13.42 34 28102 12008 70888300
Pelvic fracture 37.47 13.42 33 28103 11228 70889080
Therapeutic product effect decreased 37.30 13.42 6 28130 143012 70757296
Bone density decreased 36.94 13.42 33 28103 11441 70888867
Hyperaesthesia teeth 35.82 13.42 16 28120 1632 70898676
Product use in unapproved indication 35.52 13.42 19 28117 207459 70692849
Treatment failure 35.52 13.42 7 28129 144135 70756173
Maternal exposure during pregnancy 34.61 13.42 3 28133 115342 70784966
Hyperlipidaemia 33.09 13.42 44 28092 23819 70876489
Acute kidney injury 32.77 13.42 89 28047 474535 70425773
Hormone receptor positive HER2 negative breast cancer 32.59 13.42 8 28128 119 70900189
Spondylolisthesis 32.51 13.42 18 28118 2908 70897400
Hypotension 32.51 13.42 70 28066 404311 70495997
Rheumatoid arthritis 32.30 13.42 41 28095 291764 70608544
Diverticulum 31.99 13.42 33 28103 13660 70886648
Calcification metastatic 31.93 13.42 8 28128 130 70900178
Product use issue 31.51 13.42 16 28120 179921 70720387
Bladder hypertrophy 31.50 13.42 11 28125 584 70899724
Rib fracture 31.01 13.42 44 28092 25312 70874996
Spinal fracture 30.82 13.42 35 28101 16132 70884176
Lower respiratory tract infection 30.80 13.42 4 28132 111909 70788399
Bursitis 30.75 13.42 45 28091 26628 70873680
Metastases to lymph nodes 30.60 13.42 27 28109 9211 70891097
Oesophageal stenosis 29.75 13.42 19 28117 3985 70896323
Carcinoembryonic antigen increased 29.68 13.42 15 28121 2015 70898293
Hiatus hernia 29.36 13.42 39 28097 21095 70879213
Compression fracture 29.21 13.42 22 28114 6009 70894299
Dental fistula 29.08 13.42 10 28126 507 70899801
Drug intolerance 29.05 13.42 28 28108 225659 70674649
Jaw fistula 28.46 13.42 7 28129 105 70900203
Osteomalacia 28.25 13.42 13 28123 1421 70898887
Radius fracture 28.06 13.42 17 28119 3249 70897059
Osteogenesis imperfecta 27.48 13.42 8 28128 234 70900074
Chest pain 27.38 13.42 182 27954 251078 70649230
Bone sequestrum 27.34 13.42 12 28124 1174 70899134
Bone loss 27.16 13.42 15 28121 2412 70897896
Gingival swelling 26.79 13.42 18 28118 4111 70896197
Congenital coronary artery malformation 26.11 13.42 6 28130 66 70900242
Hip fracture 26.03 13.42 43 28093 28220 70872088
Intentional overdose 25.96 13.42 4 28132 98431 70801877
Osteoporotic fracture 25.77 13.42 17 28119 3767 70896541
Renal cyst 25.63 13.42 29 28107 13316 70886992
Vertebral foraminal stenosis 25.39 13.42 11 28125 1043 70899265
Pulpitis dental 25.34 13.42 11 28125 1048 70899260
Injection site swelling 25.18 13.42 54 28082 43103 70857205
Oral disorder 24.80 13.42 24 28112 9205 70891103
Oesophagitis 24.37 13.42 37 28099 22615 70877693
Rectocele 24.14 13.42 9 28127 577 70899731
Creatinine renal clearance increased 24.01 13.42 10 28126 860 70899448
Therapeutic product effect incomplete 23.60 13.42 9 28127 119873 70780435
Scoliosis 23.53 13.42 20 28116 6491 70893817
Metastases to pleura 23.04 13.42 11 28125 1307 70899001
Intervertebral disc degeneration 23.02 13.42 28 28108 13872 70886436
Pain 22.86 13.42 363 27773 628453 70271855
Pneumonia 22.75 13.42 141 27995 596091 70304217
Mucosal ulceration 22.57 13.42 12 28124 1789 70898519
Haemorrhoids 22.33 13.42 38 28098 25550 70874758
Osteocalcin decreased 22.20 13.42 5 28131 50 70900258
Breast cancer 21.94 13.42 44 28092 33505 70866803
Tonsillar disorder 21.81 13.42 10 28126 1084 70899224
Purulence 21.38 13.42 12 28124 1991 70898317
Breast mass 21.37 13.42 18 28118 5767 70894541
Dental necrosis 21.18 13.42 6 28130 159 70900149
Gastritis 20.71 13.42 51 28085 44540 70855768
Tooth avulsion 20.46 13.42 5 28131 73 70900235
Synovitis 20.45 13.42 13 28123 129215 70771093
Dorsal ramus syndrome 20.17 13.42 4 28132 20 70900288
Muscle spasms 20.16 13.42 117 28019 153929 70746379
Infusion site extravasation 19.98 13.42 20 28116 7988 70892320
Induration 19.94 13.42 11 28125 1765 70898543
Thoracic vertebral fracture 19.92 13.42 16 28120 4798 70895510
Oxygen saturation decreased 19.43 13.42 11 28125 116418 70783890
Suicide attempt 19.29 13.42 4 28132 79506 70820802
Cataract 19.17 13.42 57 28079 55588 70844720
Confusional state 19.09 13.42 54 28082 284344 70615964
Ovarian cancer stage III 18.98 13.42 6 28130 233 70900075
Uterine disorder 18.72 13.42 11 28125 1988 70898320
Fractured sacrum 18.65 13.42 10 28126 1516 70898792
Joint swelling 18.57 13.42 46 28090 253165 70647143
Meniscus injury 18.41 13.42 17 28119 6150 70894158
Blood parathyroid hormone increased 18.38 13.42 13 28123 3224 70897084
Dysphagia 18.37 13.42 91 28045 112743 70787565
Respiratory failure 18.35 13.42 24 28112 168711 70731597
Breath odour 18.30 13.42 10 28126 1574 70898734
Barrett's oesophagus 18.28 13.42 8 28128 777 70899531
Metastases to liver 18.21 13.42 35 28101 25843 70874465
Spondylolysis 17.92 13.42 5 28131 125 70900183
Systemic lupus erythematosus 17.92 13.42 9 28127 101893 70798415
Tooth infection 17.86 13.42 27 28109 16436 70883872
Hypothyroidism 17.83 13.42 49 28087 45706 70854602
Atrophic vulvovaginitis 17.83 13.42 9 28127 1206 70899102
Platelet count decreased 17.74 13.42 27 28109 178195 70722113
Poor dental condition 17.74 13.42 7 28129 524 70899784
Cellulitis 17.71 13.42 82 28054 98846 70801462
Bone lesion excision 17.58 13.42 4 28132 42 70900266
Hypophosphataemic osteomalacia 17.51 13.42 6 28130 301 70900007
Chest wall tumour 17.41 13.42 4 28132 44 70900264
Invasive ductal breast carcinoma 17.31 13.42 16 28120 5793 70894515
Hypercholesterolaemia 17.27 13.42 28 28108 18089 70882219
Cardiac arrest 17.11 13.42 23 28113 159811 70740497
Chronic hepatic failure 16.93 13.42 8 28128 928 70899380
Lumbar vertebral fracture 16.90 13.42 16 28120 5971 70894337
White blood cell count decreased 16.72 13.42 26 28110 170115 70730193
Eructation 16.72 13.42 20 28116 9740 70890568
Injection site phlebitis 16.60 13.42 5 28131 165 70900143
Intentional product use issue 16.53 13.42 14 28122 120128 70780180
Pulmonary oedema 16.49 13.42 6 28130 82272 70818036
Hepatic enzyme increased 16.39 13.42 23 28113 156967 70743341
Product dose omission issue 16.34 13.42 39 28097 217429 70682879
COVID-19 16.24 13.42 11 28125 105746 70794562
Lymphoedema 16.11 13.42 21 28115 11148 70889160
Cardio-respiratory arrest 16.11 13.42 10 28126 100667 70799641
Peritoneal disorder 16.10 13.42 7 28129 669 70899639
Phlebitis 16.06 13.42 18 28118 8176 70892132
Intramedullary rod insertion 16.05 13.42 5 28131 185 70900123
X-ray of pelvis and hip abnormal 15.68 13.42 3 28133 12 70900296
Lumbar spinal stenosis 15.58 13.42 14 28122 4889 70895419
Rotator cuff syndrome 15.43 13.42 22 28114 12712 70887596
Stress urinary incontinence 15.10 13.42 9 28127 1671 70898637
Cerumen impaction 15.09 13.42 8 28128 1186 70899122
Nasopharyngitis 15.05 13.42 42 28094 222164 70678144
Musculoskeletal chest pain 14.95 13.42 30 28106 22851 70877457
Death 14.92 13.42 130 28006 509931 70390377
Teeth brittle 14.89 13.42 6 28130 474 70899834
Skeletal injury 14.67 13.42 8 28128 1255 70899053
Wound haemorrhage 14.58 13.42 12 28124 3725 70896583
Hand fracture 14.37 13.42 14 28122 5413 70894895
Bone lesion 14.36 13.42 14 28122 5416 70894892
Macular scar 14.30 13.42 4 28132 101 70900207
Metastases to the mediastinum 14.17 13.42 6 28130 538 70899770
Humerus fracture 14.08 13.42 17 28119 8361 70891947
Wrist fracture 13.98 13.42 19 28117 10497 70889811
Lumbar radiculopathy 13.96 13.42 9 28127 1917 70898391
Breast disorder 13.87 13.42 9 28127 1940 70898368
Uterine leiomyoma 13.77 13.42 14 28122 5693 70894615
Bone marrow oedema 13.71 13.42 8 28128 1427 70898881
Hypercalcaemia 13.57 13.42 37 28099 34348 70865960
Gingival pain 13.51 13.42 15 28121 6742 70893566
Hospitalisation 13.49 13.42 8 28128 82560 70817748
Rectal polyp 13.48 13.42 8 28128 1472 70898836
Blister 13.48 13.42 12 28124 100514 70799794

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC M05BA06 MUSCULO-SKELETAL SYSTEM
DRUGS FOR TREATMENT OF BONE DISEASES
DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Bisphosphonates
ATC M05BB09 MUSCULO-SKELETAL SYSTEM
DRUGS FOR TREATMENT OF BONE DISEASES
DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Bisphosphonates, combinations
FDA CS M0006519 Diphosphonates
FDA EPC N0000175579 Bisphosphonate
MeSH PA D050071 Bone Density Conservation Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Hypercalcemia indication 66931009 DOID:12678
Postmenopausal osteoporosis indication 102447009
Gastritis contraindication 4556007 DOID:4029
Hypocalcemia contraindication 5291005
Bone pain contraindication 12584003
Heartburn contraindication 16331000
Esophagitis contraindication 16761005 DOID:11963
Swallowing painful contraindication 30233002
Ulcer of esophagus contraindication 30811009
Vitamin D deficiency contraindication 34713006
Dysphagia contraindication 40739000
Achalasia of esophagus contraindication 45564002 DOID:9164
Joint pain contraindication 57676002
Acute nephropathy contraindication 58574008
Stricture of esophagus contraindication 63305008
Muscle pain contraindication 68962001
Fracture of femur contraindication 71620000
Duodenitis contraindication 72007001 DOID:8643
Bed-ridden contraindication 160685001
Acute peptic ulcer contraindication 196682000
Tooth disorder contraindication 234947003 DOID:1091
Esophageal dysmotility contraindication 266434009 DOID:9192
Primary malignant neoplasm contraindication 372087000
Aseptic necrosis of bone of jaw contraindication 441809006
Invasive Dental Procedure contraindication




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 3.98 acidic
pKa2 4.97 acidic
pKa3 9.03 acidic
pKa4 13.3 acidic
pKa5 7.94 Basic

Orange Book patent data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRoutePatent numberPatent expiration datePatent use
EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** BONIVA HOFFMANN LA ROCHE N021455 March 24, 2005 DISCN TABLET ORAL 7192938 May 6, 2023 TREATMENT AND PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN BY ONCE-MONTHLY ORAL ADMINISTRATION OF IBANDRONATE SODIUM MONOHYDRATE EQUIVALENT TO 150MG OF IBANDRONIC ACID
EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** BONIVA HOFFMANN LA ROCHE N021455 March 24, 2005 DISCN TABLET ORAL 7410957 May 6, 2023 TREATMENT AND PREVENTION OF OSTEOPOROSIS
EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** BONIVA HOFFMANN LA ROCHE N021455 March 24, 2005 DISCN TABLET ORAL 7718634 May 6, 2023 TREATMENT AND PREVENTION OF OSTEOPOROSIS

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Farnesyl pyrophosphate synthase Enzyme INHIBITOR Ki 8.44 CHEMBL CHEMBL
Geranylgeranyl pyrophosphate synthase Enzyme IC50 4.10 CHEMBL
Squalene synthase Enzyme IC50 6.19 CHEMBL
Farnesyl pyrophosphate synthase Enzyme INHIBITOR IC50 5.13 IUPHAR

External reference:

IDSource
D08056 KEGG_DRUG
138926-19-9 SECONDARY_CAS_RN
4021407 VANDF
C0379200 UMLSCUI
BFQ PDB_CHEM_ID
CHEMBL997 ChEMBL_ID
CHEMBL3989569 ChEMBL_ID
CHEMBL1201008 ChEMBL_ID
DB00710 DRUGBANK_ID
D000077557 MESH_DESCRIPTOR_UI
60852 PUBCHEM_CID
3059 IUPHAR_LIGAND_ID
7189 INN_ID
UMD7G2653W UNII
115264 RXNORM
188271 MMSL
67270 MMSL
d05357 MMSL
007178 NDDF
007179 NDDF
395271007 SNOMEDCT_US
404839003 SNOMEDCT_US
420936009 SNOMEDCT_US
96287002 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Boniva HUMAN PRESCRIPTION DRUG LABEL 1 0004-0186 TABLET, FILM COATED 150 mg ORAL NDA 27 sections
ibandronate sodium HUMAN PRESCRIPTION DRUG LABEL 1 25021-827 INJECTION, SOLUTION 3 mg INTRAVENOUS ANDA 30 sections
IBANDRONATE SODIUM Human Prescription Drug Label 1 33342-150 TABLET, FILM COATED 150 mg ORAL ANDA 27 sections
IBANDRONATE SODIUM Human Prescription Drug Label 1 33342-150 TABLET, FILM COATED 150 mg ORAL ANDA 27 sections
IBANDRONATE SODIUM HUMAN PRESCRIPTION DRUG LABEL 1 47781-103 TABLET 150 mg ORAL ANDA 27 sections
IBANDRONATE SODIUM HUMAN PRESCRIPTION DRUG LABEL 1 47781-103 TABLET 150 mg ORAL ANDA 27 sections
IBANDRONATE SODIUM HUMAN PRESCRIPTION DRUG LABEL 1 51224-008 INJECTION, SOLUTION 3 mg INTRAVENOUS ANDA 31 sections
IBANDRONATE SODIUM HUMAN PRESCRIPTION DRUG LABEL 1 51224-008 INJECTION, SOLUTION 3 mg INTRAVENOUS ANDA 31 sections
Boniva HUMAN PRESCRIPTION DRUG LABEL 1 54868-5322 TABLET, FILM COATED 150 mg ORAL NDA 28 sections
Ibandronate sodium HUMAN PRESCRIPTION DRUG LABEL 1 55111-575 TABLET 150 mg ORAL ANDA 26 sections
Ibandronate Sodium Human Prescription Drug Label 1 55150-191 INJECTION, SOLUTION 3 mg INTRAVENOUS ANDA 27 sections
Ibandronate Sodium Human Prescription Drug Label 1 55150-191 INJECTION, SOLUTION 3 mg INTRAVENOUS ANDA 27 sections
IBANDRONATE SODIUM HUMAN PRESCRIPTION DRUG LABEL 1 60429-643 TABLET, FILM COATED 150 mg ORAL ANDA 28 sections
IBANDRONATE SODIUM HUMAN PRESCRIPTION DRUG LABEL 1 60505-2795 TABLET, FILM COATED 150 mg ORAL ANDA 28 sections
Ibandronate Sodium HUMAN PRESCRIPTION DRUG LABEL 1 60505-6097 INJECTION 3 mg INTRAVENOUS ANDA 28 sections
Ibandronate Sodium HUMAN PRESCRIPTION DRUG LABEL 1 60505-6097 INJECTION 3 mg INTRAVENOUS ANDA 28 sections
IBANDRONATE SODIUM Human Prescription Drug Label 1 62756-218 INJECTION, SOLUTION 3 mg INTRAVENOUS ANDA 28 sections
Ibandronate Sodium Human Prescription Drug Label 1 65862-237 TABLET, FILM COATED 150 mg ORAL ANDA 27 sections
ibandronate sodium HUMAN PRESCRIPTION DRUG LABEL 1 67457-524 INJECTION, SOLUTION 3 mg INTRAVENOUS ANDA 23 sections